Vanguard National Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Vanguard National Trust's BMY Position: Q2 2026 in Review
Vanguard National Trust increased its Bristol-Myers Squibb (BMY) stake by 19% in Q2 2026, buying an estimated $21.4K and bringing the position to 2,369 shares worth $137K. The position accounts for 0.01% of the portfolio, ranked #320.
Vanguard National Trust first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,494 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Vanguard National Trust held 2,369 shares of Bristol-Myers Squibb worth $137K as of Q2 2026.
- Vanguard National Trust bought 372 Bristol-Myers Squibb shares in Q2 2026, an estimated $21.4K.
- Bristol-Myers Squibb made up 0.01% of Vanguard National Trust's portfolio in Q2 2026, its #320 holding.
- Vanguard National Trust first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 2,494 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.